Written by Alliance Life Sciences Managing Consultant Charlene Washer and published in Pharmaceutical Processing’s April 2016 issue.
“In today’s environment, pharmaceutical manufacturers (pharmcos) are tasked with meeting statutory requirements for discount and liability accruals with greater specificity. Given the increasing diversity and complexity of current marketing and contracting offerings, this has never been more challenging. As a result, pharmcos are wisely investing time and resources to improve the gross-to-net (GTN) management process using forecasts to reconcile these items.”
Download a copy now:
Overcoming Statutory Barriers With Gross-to-Net Analytics
In today’s environment, pharmaceutical manufacturers (pharmcos) are tasked with meeting statutory requirements…